EREVAN, JULY 28, ARMENPRESS. Armenia has pursued a policy of getting rid of viral hepatitis as part of the 2022-2030 strategy, the Health Ministry said.
The purpose is to particularly decrease prevalence by 2030 through the integration of patient care and remedy services.
Since 2020, patients with chronic viral hepatitis C receive antiviral drugs for free. To ensure the continuity of the program, the regulation of the remedy with new drugs was recently approved.
517 patients won the hepatitis C remedy in Armenia in 2022.
Since 1999, hepatitis B vaccines have been carried out in Armenia, resulting in no acute cases of hepatitis B in children under 14 years of age.
Viral hepatitis remains one of the leading causes of death worldwide, with more than a million people dying from the disease each year.
There is still no vaccine for hepatitis C.
Common modes of transmission of these viruses include receiving infected blood or blood products, invasive medical procedures, infected equipment, and transmission of hepatitis B from mother to baby at birth, from a family member to child, as well as through sexual contact.
Early diagnosis of viral hepatitis is very much in favor of treatment, so normal testing is recommended as the disease may have an asymptomatic course.
Free and unnamed tests are held in Yerevan and other cities.